Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Experts in MS discuss the evolution in treatment options over time and the shift towards use of early high-efficacy therapy. Neil Minkoff, MD: As someone who’s been involved in medication management, ...

Multiple sclerosis (MS) is an insidious disease. Patients suffer because their immune system is attacking their own nerve fibres, which inhibits the transmission of nerve signals. People with MS ...

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS). The Consortium of Multiple Sclerosis Centers ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

The symptoms of MS vary widely in location and severity among individuals. Common symptoms include fatigue, numbness, focal weakness, visual changes such as unilateral visual loss and diplopia, ...

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS). The Consortium of Multiple Sclerosis Centers ...

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

A new study demonstrated that treatment timing of multiple sclerosis (MS) does inform long-term disability. Patients who began treatment 3 years after the onset of MS had an increased risk of ...

Being diagnosed with multiple sclerosis can, naturally, have an enormous impact on your life. You may need to make some lifestyle changes and try a few treatments to help manage the various symptoms, ...